Lv4
434 积分 2025-07-10 加入
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
13天前
已完结
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
25天前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
2个月前
已完结
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
2个月前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2个月前
已完结
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
2个月前
已完结
Exploring the next generation of antibody–drug conjugates
5个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
5个月前
已完结
Exploring the next generation of antibody–drug conjugates
6个月前
已完结
Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity
6个月前
已完结
皖公网安备34019202002308
